SEPTEMBER 30, 2005
VOLUME 2 NO. 16

PATIENTS & PRACTICE

Blood with too much iron in it

A cure for hemochromatosis is on the horizon.
For now, giving is the only way to go


The good news about hemochromatosis is that it has the potential to save the lives of others. The bad news is that the genetic blood disorder in which the body absorbs too much iron leads to a host of potential health problems ranging from impotence to diabetes mellitus to cirrhosis of the liver. Fortunately, if the patient's hemochromatosis is caught early enough it's quite simple to treat the disorder — a blood draw is usually all it takes to get a patient's iron level down to an acceptable level. But sadly, this iron-rich bloodletting routine usually has to be kept up periodically for the rest of a patient's life. In the rare cases where readings show that an unsafe amount of blood would need to be drawn to get iron levels down, docs must turn to deferoxamine injections which bind to iron in patients' blood — next stop the kidneys —then finally the iron-laced deferoxamine gets tinkled out.

Hemochromatosis is sometimes called "The Bronze Disease" due to the permanent tan that develops in untreated cases. One of the first detectable signs of the disorder is joint pain or arthritis in the knuckles of the index and middle fingers.

Unfortunately there's still no simple inexpensive screening test for the disorder. An accurate but costly genetic test does exist and it's a good idea to run it on folks with a family history or if you suspect it in a patient with one or more of the following symptoms: high liver enzymes, joint disease, severe fatigue, heart disease, sexual dysfunction or diabetes.

WHAT CAUSES IT?
Until quite recently, hemochromatosis was thought to be very rare, but now it's believed that about one in every 250 Caucasians has the disorder and that between 10-15% of the population carries the gene responsible. It is much less common among non-Caucasians. A groundbreaking paper on the cause of hemochromatosis was published in March in the journal Cell Metabolism. The investigators, based at the Children's Hospital Boston and Harvard Medical School, were the first to find solid evidence that the protein ferroportin is the culprit behind the disorder. Future treatments will likely use drugs that inhibit ferroportin — but what of the here and now?

DRAWING TO A CURE
Today the best and simplest way to treat hemochromatosis remains the phlebotomy, the drawing of blood. This can be disconcerting to a patient. Mike, an IT professional from Quebec who suffers from the disease, says "My initial reaction was that the treatment was something from the Dark Ages." It's believed to be widely under-diagnosed and Mike, whose wife is a family physician, is a case study in how difficult it can be to pinpoint the hodgepodge of symptoms. When he was finally diagnosed he felt relieved. "My symptoms had my doctor looking for something much worse," he says "and the diagnosis made sense out of a lot of vague symptoms I'd had all my adult life."

SANGUINARY SYNERGY
The blood that's drawn from patients with hemochromatosis is usually perfectly good and suitable for use in other patients but until recently it's been mostly just thrown away. Since 2001 the Canadian Hemochromatosis Society and Canadian Blood Services (CBS) have been trying to do something about this. Together the two organizations launched an appeal for hemochromatosis patients to give blood at a CBS site every 56 days. CBS CEO Dr Graham Sher says "By donating their blood at Canadian Blood Services, a person with hemochromatosis will be helping to save the lives of up to four people."

LIVING WITH IT
While phlebotomies aren't the most invasive treatment imaginable they still can be quite a trial on sufferers. "...treatments and tests do eat into my time," says Mike. "Also, one nurse in the clinic I go to is absolutely useless for phlebotomies, she can never hit a vein on first try, thankfully the appointment staff are aware of this and help me to schedule appointments for when she's not on duty."

The Canadian Hemochromatosis Society is currently running an awareness drive. They're offering glow-in-the-dark hemochromatosis wristbands for $7.50. For more information please visit their website at www.cdnhemochromatosis.ca.

 

 

back to top of page

 

 

 

 
 
© Parkhurst Publishing Privacy Statement
Legal Terms of Use
Site created by Spin Design T.